FTC to regulate false advertising of nonprescription sleep aids
Washington FTC plans rules to ban false advertising for nonprescription sleeping aids rather than suing individual manufacturers. Acting director Mean Bernstein said action against firms is not yet warranted despite questions on efficacy and safety. FDA reports on each drug are required before action. Americans spend over 50 billion annually on such products. 1972 ads totaled about 10.2 million. Major products include Sominex Nytel Quiet World and Nergine.
MENTIONED IN THIS ARTICLE
Washington
Federal Trade Commission
FTC
Mean Z. Bernstein
Bureau of Consumer Protection
Senate
Small Business
Food and Trug Administration
Also Mentioned on This Page
Sominex
J. B. Williams Co. Inc
New York City
Nabisco
Nytel
Black Drug Co
Jersey City
N.J
Quiet World
American Home Products
Nergine
Miles Laboratories
Elkhart
Ind
Dickens
Enemy
Columbus
Bank Americars
AMC
SALE
Remington
Kemiington
Winchester
Ithaca
Spring Field
V.n. Reg
Beretta Garonne V.T
Universal
Parker
Lambert
Skik
Allis Chalmers
Sizas
Ayrsway
Ayr Way
Anderson
Scatterfield Road